Medical Properties Trust, Inc. MPT

3.57 (0.03) (0.83%) as of 25 Sep
Market cap
$2.1B
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Revenue
541.14 704.75 784.52 854.20 1,249.24 1,544.67 1,542.85 871.80 995.55 972.02
Revenue Growth
22.46% 30.23% 11.32% 8.88% 46.25% 23.65% (0.12%) (43.49%) 14.19% (2.36%)
Cost of Revenue
2.71 5.81 9.24 23.99 24.89 39.10 45.70 41.57 27.26 36.42
Gross Profit
538.43 698.93 775.29 830.21 1,224.35 1,505.57 1,497.15 830.23 968.29 935.61
SG&A Expenses
48.91 58.60 81.00 96.41 131.66 145.64 160.49 145.59 133.79 130.43
Operating Income
182.04 308.63 337.93 343.65 499.71 671.29 644.65 (329.89) (30.98) 29.41
Non-operating Income/Expense
37.07 (14.71) 681.48 30.13 (36.38) 59.60 315.07 (356.88) (2,333.21) (266.73)
EBT
219.11 293.92 1,019.40 373.78 463.33 730.89 959.72 (686.77) (2,364.19) (237.32)
Income Tax Provision
(6.83) 2.68 0.93 (2.62) 31.06 73.95 55.90 (130.68) 44.10 38.62
Income after Tax
225.94 291.24 1,018.48 376.40 432.27 656.94 903.82 (556.09) (2,408.29) (275.94)
Dividends (Preferred)
0.00 — — — — — — 0.00 — —
Non-Controlling Interest
0.89 1.45 1.79 1.72 0.82 0.92 1.22 0.38 1.98 1.11
Net Income Common
225.05 289.79 1,016.69 374.68 431.45 656.02 902.60 (556.48) (2,410.27) (277.05)
EPS (Basic)
0.86 0.82 2.77 0.88 0.81 1.11 1.50 (0.93) (4.02) (0.46)
EPS (Diluted)
0.86 0.82 2.76 0.87 0.81 1.11 1.50 (0.93) (4.02) (0.46)
Shares (Basic, Weighted)
260.41 349.90 365.36 427.08 529.24 588.82 598.63 598.52 600.25 600.89
Shares (Diluted, Weighted)
261.07 350.44 366.27 428.30 530.46 590.14 598.84 598.52 600.25 600.89
Gross Margin
99.50% 99.18% 98.82% 97.19% 98.01% 97.47% 97.04% 95.23% 97.26% 96.25%
EBIT Margin
33.64% 43.79% 43.07% 40.23% 40.00% 43.46% 41.78% (37.84%) (3.11%) 3.03%
EBT margin
40.49% 41.71% 129.94% 43.76% 37.09% 47.32% 62.20% (78.78%) (237.48%) (24.41%)
Net Profit Margin
41.59% 41.12% 129.59% 43.86% 34.54% 42.47% 58.50% (63.83%) (242.11%) (28.50%)
Free Cash Flow Margin
53.85% 50.06% 243.31% 61.12% 51.51% 64.12% 182.48% 147.84% 202.88% 27.91%
EBITDA
287.26 447.13 486.78 509.11 788.76 1,021.93 1,007.27 302.02 440.12 328.51
EBIT
182.04 308.63 337.93 343.65 499.71 671.29 644.65 (329.89) (30.98) 29.41
Income from Continuous Operations
225.94 291.24 1,018.48 376.40 432.27 656.94 903.82 (556.09) (2,408.29) (275.94)
Consolidated Net Income/Loss
225.94 291.24 1,018.48 376.40 432.27 656.94 903.82 (556.09) (2,408.29) (275.94)
EPS (Basic, from Continuous Ops)
0.87 0.83 2.79 0.88 0.82 1.12 1.51 (0.93) (4.01) (0.46)
EPS (Basic, Consolidated)
0.87 0.83 2.79 0.88 0.82 1.12 1.51 (0.93) (4.01) (0.46)
EPS (Diluted, from Cont. Ops)
0.87 0.83 2.78 0.88 0.81 1.11 1.51 (0.93) (4.01) (0.46)
Shares (Diluted, Average)
261.07 350.44 366.27 428.30 530.46 590.14 598.84 598.52 600.25 600.89
EPS (Diluted, Consolidated)
0.87 0.83 2.78 0.88 0.81 1.11 1.51 (0.93) (4.01) (0.46)
EBITDA Margin
53.08% 63.45% 62.05% 59.60% 63.14% 66.16% 65.29% 34.64% 44.21% 33.80%
Operating Cash Flow Margin
48.76% 51.40% 57.24% 57.85% 49.44% 52.55% 47.90% 58.02% 24.66% 23.74%

Fold the line items

In millions of $ except per-share values · columns are period end dates